Hanmi scraps lung cancer drug due to AstraZeneca rival, reports say

Hanmi scraps lung cancer drug due to AstraZeneca rival, reports say

Source: 
Biopharma Dive
snippet: 

Hanmi Pharm Co. Ltd. is shelving its lung cancer drug Olita because of the more advantageous position a rival therapy holds in the market, The Korean Herald reports.